Clinical Trials Logo

Clinical Trial Summary

The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.


Clinical Trial Description

The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device. This trial is a prospective, multicenter single-arm study. Up to 220 subjects will be enrolled at up to 20 participating investigational sites. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04852783
Study type Interventional
Source Cerus Endovascular, Ltd
Contact Carin Lindquist
Phone (510) 946-2787
Email Carin.Lindquist@stryker.com
Status Recruiting
Phase Phase 4
Start date August 6, 2021
Completion date July 2029

See also
  Status Clinical Trial Phase
Recruiting NCT03117803 - The Natural Course of Unruptured Intracranial Aneurysms in a Chinese Cohort N/A
Terminated NCT05544045 - China Surpass Streamline Post-Market Study
Not yet recruiting NCT02820779 - New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry N/A
Active, not recruiting NCT04195568 - Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System N/A
Withdrawn NCT04886505 - An EFS Assessing the Electrolytic eCLIPs System for Treatment of Intracranial Aneurysms N/A
Recruiting NCT05029947 - Setting Benchmarks for Microsurgical Clipping of Unruptured Intracranial Aneurysms
Completed NCT02354300 - Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization N/A